How Participants Perceive Biomedical Research in Pulmonology
NCT ID: NCT03397056
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2018-03-07
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Criteria Associated With Patient Willingness to Participate in Biomedical Research
NCT03098303
Biological Determinants of Sputum Rheology in Chronic Airway Diseases
NCT04081740
Prevalence and Characterization of Persistent Dyspnea After Hospitalization
NCT03798158
Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01007734
Chronic Obstructive Pulmonary Disease Patient Preferences Survey
NCT02970422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health.
The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.
The secondary objectives are to determine:
* how biomedical research is experienced / felt;
* if the information delivered to the patient (orally - information note) is clearly perceived.
Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The study population
The target population corresponds to patients with a respiratory disease already included in a biomedical research protocol.
Intervention: Questionnaire
Questionnaire
The Questionnaire is provided in the links at the end of the declaration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
The Questionnaire is provided in the links at the end of the declaration.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient is participating in a biomedical research protocol.
Exclusion Criteria
* Patient judged incapable of filling out the questionnaire for linguistic or other reasons.
* The patient has already participated in the present study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Bourdin, MD, PhD
Role: STUDY_DIRECTOR
University Hospitals of Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
APHM - Hôpital Nord
Marseille, , France
CHRU Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
PROTOACCEPT2 on the Open Science Framework (access to questionnaire)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL17_0447
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.